BIOLASE, Inc. (BIOL)
USD 0.02
(27.39%)
USD 0.02
(27.39%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 34.66 Million USD | -15.97% |
| 2022 | 41.24 Million USD | 26.36% |
| 2021 | 32.64 Million USD | 32.12% |
| 2020 | 24.7 Million USD | -17.39% |
| 2019 | 29.9 Million USD | -14.78% |
| 2018 | 35.09 Million USD | 7.46% |
| 2017 | 32.65 Million USD | -7.4% |
| 2016 | 35.27 Million USD | -3.62% |
| 2015 | 36.59 Million USD | 1.34% |
| 2014 | 36.11 Million USD | 11.03% |
| 2013 | 32.52 Million USD | 12.12% |
| 2012 | 29 Million USD | 14.56% |
| 2011 | 25.32 Million USD | 24.83% |
| 2010 | 20.28 Million USD | -11.89% |
| 2009 | 23.02 Million USD | -41.9% |
| 2008 | 39.62 Million USD | -8.9% |
| 2007 | 43.49 Million USD | 5.25% |
| 2006 | 41.32 Million USD | -13.52% |
| 2005 | 47.78 Million USD | 5.33% |
| 2004 | 45.36 Million USD | 88.18% |
| 2003 | 24.11 Million USD | 54.39% |
| 2002 | 15.61 Million USD | 42.59% |
| 2001 | 10.95 Million USD | 26.94% |
| 2000 | 8.62 Million USD | 11.86% |
| 1999 | 7.71 Million USD | 45.53% |
| 1998 | 5.3 Million USD | 60.61% |
| 1997 | 3.3 Million USD | 22.22% |
| 1996 | 2.7 Million USD | 8.0% |
| 1995 | 2.5 Million USD | -40.48% |
| 1994 | 4.2 Million USD | -44.74% |
| 1993 | 7.6 Million USD | 0.0% |
| 1992 | 7.6 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 7.86 Million USD | -8.58% |
| 2024 Q2 | 7.82 Million USD | -0.42% |
| 2023 Q3 | 7.44 Million USD | -25.5% |
| 2023 Q1 | 8.62 Million USD | -28.24% |
| 2023 Q4 | 8.6 Million USD | 15.54% |
| 2023 FY | 34.66 Million USD | -15.97% |
| 2023 Q2 | 9.99 Million USD | 15.79% |
| 2022 Q2 | 10.19 Million USD | 14.11% |
| 2022 Q4 | 12.02 Million USD | 19.09% |
| 2022 FY | 41.24 Million USD | 26.36% |
| 2022 Q3 | 10.09 Million USD | -0.98% |
| 2022 Q1 | 8.93 Million USD | -2.99% |
| 2021 Q3 | 7.47 Million USD | 3.01% |
| 2021 Q4 | 9.21 Million USD | 23.29% |
| 2021 FY | 32.64 Million USD | 32.12% |
| 2021 Q1 | 8.8 Million USD | 23.22% |
| 2021 Q2 | 7.25 Million USD | -17.62% |
| 2020 Q3 | 5.94 Million USD | 20.75% |
| 2020 Q2 | 4.92 Million USD | -26.62% |
| 2020 Q1 | 6.7 Million USD | -10.18% |
| 2020 FY | 24.7 Million USD | -17.39% |
| 2020 Q4 | 7.14 Million USD | 20.25% |
| 2019 Q4 | 7.46 Million USD | -4.92% |
| 2019 FY | 29.9 Million USD | -14.78% |
| 2019 Q2 | 6.9 Million USD | -10.25% |
| 2019 Q1 | 7.69 Million USD | -18.47% |
| 2019 Q3 | 7.85 Million USD | 13.67% |
| 2018 Q1 | 8.21 Million USD | 4.94% |
| 2018 FY | 35.09 Million USD | 7.46% |
| 2018 Q4 | 9.44 Million USD | 11.7% |
| 2018 Q3 | 8.45 Million USD | -5.96% |
| 2018 Q2 | 8.98 Million USD | 9.37% |
| 2017 Q1 | 8.02 Million USD | -15.64% |
| 2017 Q3 | 7.61 Million USD | -17.07% |
| 2017 Q4 | 7.83 Million USD | 2.81% |
| 2017 FY | 32.65 Million USD | -7.4% |
| 2017 Q2 | 9.18 Million USD | 14.39% |
| 2016 FY | 35.27 Million USD | -3.62% |
| 2016 Q4 | 9.51 Million USD | 8.73% |
| 2016 Q3 | 8.75 Million USD | -3.21% |
| 2016 Q2 | 9.04 Million USD | 13.65% |
| 2016 Q1 | 7.95 Million USD | 0.3% |
| 2015 Q3 | 8.73 Million USD | -18.61% |
| 2015 Q4 | 7.93 Million USD | -9.16% |
| 2015 FY | 36.59 Million USD | 1.34% |
| 2015 Q2 | 10.73 Million USD | 16.63% |
| 2015 Q1 | 9.2 Million USD | 3.05% |
| 2014 FY | 36.11 Million USD | 11.03% |
| 2014 Q2 | 9.92 Million USD | 15.68% |
| 2014 Q3 | 8.68 Million USD | -12.43% |
| 2014 Q4 | 8.92 Million USD | 2.76% |
| 2014 Q1 | 8.57 Million USD | 2.44% |
| 2013 Q4 | 8.37 Million USD | 8.87% |
| 2013 Q3 | 7.69 Million USD | -2.08% |
| 2013 Q2 | 7.85 Million USD | -8.8% |
| 2013 Q1 | 8.61 Million USD | 11.86% |
| 2013 FY | 32.52 Million USD | 12.12% |
| 2012 FY | 29 Million USD | 14.56% |
| 2012 Q4 | 7.69 Million USD | 15.43% |
| 2012 Q3 | 6.66 Million USD | -7.54% |
| 2012 Q2 | 7.21 Million USD | -2.91% |
| 2012 Q1 | 7.42 Million USD | -0.83% |
| 2011 Q1 | 5.24 Million USD | 18.16% |
| 2011 Q2 | 6.33 Million USD | 20.69% |
| 2011 Q3 | 6.25 Million USD | -1.17% |
| 2011 Q4 | 7.49 Million USD | 19.74% |
| 2011 FY | 25.32 Million USD | 24.83% |
| 2010 Q3 | 4.21 Million USD | -30.37% |
| 2010 Q4 | 4.43 Million USD | 5.31% |
| 2010 Q1 | 5.57 Million USD | -3.36% |
| 2010 FY | 20.28 Million USD | -11.89% |
| 2010 Q2 | 6.05 Million USD | 8.52% |
| 2009 Q4 | 5.77 Million USD | 17.1% |
| 2009 Q2 | 5.62 Million USD | -16.02% |
| 2009 FY | 23.02 Million USD | -41.9% |
| 2009 Q3 | 4.92 Million USD | -12.36% |
| 2009 Q1 | 6.69 Million USD | -20.62% |
| 2008 Q2 | 9.72 Million USD | -4.16% |
| 2008 Q1 | 10.14 Million USD | -18.26% |
| 2008 Q3 | 11.32 Million USD | 16.5% |
| 2008 FY | 39.62 Million USD | -8.9% |
| 2008 Q4 | 8.43 Million USD | -25.5% |
| 2007 Q3 | 10.17 Million USD | -6.95% |
| 2007 FY | 43.49 Million USD | 5.25% |
| 2007 Q2 | 10.93 Million USD | 9.55% |
| 2007 Q1 | 9.98 Million USD | -6.06% |
| 2007 Q4 | 12.4 Million USD | 21.98% |
| 2006 Q1 | 10.96 Million USD | 1.08% |
| 2006 FY | 41.32 Million USD | -13.52% |
| 2006 Q3 | 9.74 Million USD | -2.4% |
| 2006 Q4 | 10.62 Million USD | 8.98% |
| 2006 Q2 | 9.98 Million USD | -8.9% |
| 2005 FY | 47.78 Million USD | 5.33% |
| 2005 Q4 | 10.84 Million USD | 3.41% |
| 2005 Q3 | 10.49 Million USD | -18.14% |
| 2005 Q2 | 12.81 Million USD | -6.01% |
| 2005 Q1 | 13.63 Million USD | -29.99% |
| 2004 FY | 45.36 Million USD | 88.18% |
| 2004 Q3 | 9.36 Million USD | 7.18% |
| 2004 Q1 | 8.11 Million USD | -0.16% |
| 2004 Q2 | 8.73 Million USD | 7.63% |
| 2004 Q4 | 19.47 Million USD | 107.99% |
| 2003 FY | 24.11 Million USD | 54.39% |
| 2003 Q2 | 5.14 Million USD | 4.51% |
| 2003 Q1 | 4.92 Million USD | -3.11% |
| 2003 Q3 | 5.86 Million USD | 13.93% |
| 2003 Q4 | 8.13 Million USD | 38.6% |
| 2002 Q2 | 3.77 Million USD | 26.44% |
| 2002 Q4 | 5.08 Million USD | 35.13% |
| 2002 Q1 | 2.98 Million USD | -2.83% |
| 2002 Q3 | 3.76 Million USD | -0.4% |
| 2002 FY | 15.61 Million USD | 42.59% |
| 2001 FY | 10.95 Million USD | 26.94% |
| 2001 Q3 | 2.72 Million USD | 0.02% |
| 2001 Q1 | 2.49 Million USD | -14.05% |
| 2001 Q2 | 2.72 Million USD | 9.33% |
| 2001 Q4 | 3.07 Million USD | 12.93% |
| 2000 Q1 | 1.57 Million USD | -41.82% |
| 2000 Q4 | 2.89 Million USD | 31.78% |
| 2000 FY | 8.62 Million USD | 11.86% |
| 2000 Q3 | 2.19 Million USD | 12.57% |
| 2000 Q2 | 1.95 Million USD | 23.75% |
| 1999 FY | 7.71 Million USD | 45.53% |
| 1999 Q1 | 1.5 Million USD | -16.67% |
| 1999 Q2 | 1.8 Million USD | 20.0% |
| 1999 Q3 | 1.6 Million USD | -11.11% |
| 1999 Q4 | 2.71 Million USD | 69.57% |
| 1998 Q1 | 900 Thousand USD | 12.5% |
| 1998 FY | 5.3 Million USD | 60.61% |
| 1998 Q2 | 1.1 Million USD | 22.22% |
| 1998 Q3 | 1.5 Million USD | 36.36% |
| 1998 Q4 | 1.8 Million USD | 20.0% |
| 1997 Q1 | 800 Thousand USD | -20.0% |
| 1997 FY | 3.3 Million USD | 22.22% |
| 1997 Q4 | 800 Thousand USD | 14.29% |
| 1997 Q3 | 700 Thousand USD | -30.0% |
| 1997 Q2 | 1 Million USD | 25.0% |
| 1996 Q2 | 700 Thousand USD | 40.0% |
| 1996 Q1 | 500 Thousand USD | -16.67% |
| 1996 FY | 2.7 Million USD | 8.0% |
| 1996 Q4 | 1 Million USD | 66.67% |
| 1996 Q3 | 600 Thousand USD | -14.29% |
| 1995 Q4 | 600 Thousand USD | 50.0% |
| 1995 Q2 | 500 Thousand USD | -44.44% |
| 1995 Q1 | 900 Thousand USD | -40.0% |
| 1995 Q3 | 400 Thousand USD | -20.0% |
| 1995 FY | 2.5 Million USD | -40.48% |
| 1994 Q2 | 800 Thousand USD | 0.0% |
| 1994 Q4 | 1.5 Million USD | 66.67% |
| 1994 Q3 | 900 Thousand USD | 12.5% |
| 1994 Q1 | - USD | -100.0% |
| 1994 FY | 4.2 Million USD | -44.74% |
| 1993 Q4 | 2.2 Million USD | 29.41% |
| 1993 FY | 7.6 Million USD | 0.0% |
| 1993 Q3 | 1.7 Million USD | -15.0% |
| 1993 Q2 | 2 Million USD | 17.65% |
| 1993 Q1 | 1.7 Million USD | -37.04% |
| 1992 FY | 7.6 Million USD | 0.0% |
| 1992 Q4 | 2.7 Million USD | 107.69% |
| 1992 Q2 | 1.9 Million USD | 0.0% |
| 1992 Q3 | 1.3 Million USD | -31.58% |
| 1992 Q1 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -208.811% |
| Cerus Corporation | 143.15 Million USD | 75.788% |
| OrthoPediatrics Corp. | 137.01 Million USD | 74.704% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -205.091% |
| Talis Biomedical Corporation | 67.18 Million USD | 48.41% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -38.944% |
| Inogen, Inc. | 236.08 Million USD | 85.318% |
| Spectral AI, Inc. | 20.86 Million USD | -66.128% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 38.102% |
| CVRx, Inc. | 76.14 Million USD | 54.478% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -882.456% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -177.532% |
| Orthofix Medical Inc. | 667.42 Million USD | 94.807% |
| Venus Concept Inc. | 80.47 Million USD | 56.93% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 38.738% |
| Bioventus Inc. | 409.91 Million USD | 91.544% |
| BrainsWay Ltd. | 28.01 Million USD | -23.71% |
| Envoy Medical, Inc. | 17.89 Million USD | -93.659% |
| electroCore, Inc. | 32.03 Million USD | -8.211% |
| IceCure Medical Ltd | 16.87 Million USD | -105.386% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 18.314% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -96.569% |
| MaxCyte, Inc. | 84.84 Million USD | 59.148% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -179.259% |
| Nexalin Technology, Inc. | 5.78 Million USD | -499.531% |
| PAVmed Inc | 64.82 Million USD | 46.533% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 32.141% |
| RxSight, Inc. | 103.85 Million USD | 66.624% |
| Sight Sciences, Inc. | 126.44 Million USD | 72.589% |
| SI-BONE, Inc. | 156.35 Million USD | 77.831% |
| TELA Bio, Inc. | 84.18 Million USD | 58.829% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 50.524% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 82.956% |
| LivaNova PLC | 843.54 Million USD | 95.891% |
| 908 Devices Inc. | 68.08 Million USD | 49.088% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 92.833% |
| Nemaura Medical Inc. | 7.13 Million USD | -385.53% |
| NeuroPace, Inc. | 75.29 Million USD | 53.967% |
| LENSAR, Inc. | 33.33 Million USD | -3.975% |
| Apyx Medical Corporation | 51.01 Million USD | 32.061% |
| Cutera, Inc. | 197.72 Million USD | 82.47% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -39.869% |
| BioSig Technologies, Inc. | 28.53 Million USD | -21.49% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 81.898% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 3.88% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 95.856% |
| Axonics, Inc. | 270.2 Million USD | 87.172% |
| Outset Medical, Inc. | 198.77 Million USD | 82.562% |
| IRIDEX Corporation | 31.81 Million USD | -8.949% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 80.767% |
| IRadimed Corporation | 30.12 Million USD | -15.066% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -306.247% |
| INVO Bioscience, Inc. | 7.85 Million USD | -341.356% |
| Telesis Bio, Inc. | 63.48 Million USD | 45.406% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 64.794% |
| Varex Imaging Corporation | 224.8 Million USD | 84.581% |
| Quipt Home Medical Corp. | 148.66 Million USD | 76.685% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -195.667% |
| Pulmonx Corporation | 112.68 Million USD | 69.241% |
| Dynatronics Corporation | 9.9 Million USD | -249.828% |
| Modular Medical, Inc. | 17.52 Million USD | -97.735% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -71.7% |
| Semler Scientific, Inc. | 38.94 Million USD | 10.998% |
| InMode Ltd. | 215.68 Million USD | 83.929% |
| Bruker Corporation | 1.07 Billion USD | 96.78% |
| Cytosorbents Corporation | 48.33 Million USD | 28.293% |
| DexCom, Inc. | 1.69 Billion USD | 97.951% |
| Align Technology, Inc. | 2.07 Billion USD | 98.331% |
| Viveve Medical, Inc. | 22.17 Million USD | -56.321% |
| ZimVie Inc. | 275.12 Million USD | 87.402% |
| Movano Inc. | 29.69 Million USD | -16.743% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 74.75% |
| Nexalin Technology, Inc. | 5.78 Million USD | -499.531% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -882.456% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 94.232% |
| Profound Medical Corp. | 33.6 Million USD | -3.148% |
| Insulet Corporation | 939.9 Million USD | 96.312% |
| enVVeno Medical Corporation | 25.23 Million USD | -37.337% |
| Surmodics, Inc. | 98.69 Million USD | 64.881% |
| iCAD, Inc. | 22.22 Million USD | -55.955% |
| Nuwellis, Inc. | 22.61 Million USD | -53.279% |
| Biotricity, Inc. | 17.18 Million USD | -101.699% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 92.227% |
| Aethlon Medical, Inc. | 12.27 Million USD | -182.313% |
| InspireMD, Inc. | 22.95 Million USD | -51.028% |
| PAVmed Inc. | 64.82 Million USD | 46.533% |
| Beyond Air, Inc. | 61.7 Million USD | 43.823% |
| FONAR Corporation | 28.6 Million USD | -21.172% |
| AxoGen, Inc. | 149.33 Million USD | 76.79% |
| Vivani Medical, Inc. | 26.96 Million USD | -28.541% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 80.428% |
| Inari Medical, Inc. | 448.59 Million USD | 92.273% |
| UFP Technologies, Inc. | 58.08 Million USD | 40.331% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -603.405% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -448.582% |
| Tenon Medical, Inc. | 16.96 Million USD | -104.273% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -368.835% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 21.409% |
| AdaptHealth Corp. | 1.07 Billion USD | 96.785% |
| Sintx Technologies, Inc. | 15.2 Million USD | -128.018% |
| NanoVibronix, Inc. | 4.97 Million USD | -596.984% |
| Quanterix Corporation | 118.1 Million USD | 70.651% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -195.667% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -140.001% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 91.173% |
| TransMedics Group, Inc. | 182.82 Million USD | 81.041% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -23.503% |
| NeuroMetrix, Inc. | 11.09 Million USD | -212.291% |
| Hyperfine, Inc. | 52.87 Million USD | 34.444% |
| Establishment Labs Holdings Inc. | 172 Million USD | 79.849% |
| Biomerica, Inc. | 6.97 Million USD | -396.718% |
| Bone Biologics Corporation | 9.42 Million USD | -267.627% |
| AVITA Medical, Inc. | 80.77 Million USD | 57.092% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -236.149% |
| Silk Road Medical, Inc | 186.35 Million USD | 81.401% |